All rats that were vaccinated with the BK channel activated/killed T9 cells or T9-C2 cells produced specific immunity towards the T9 glioma cells (Figure 11B) but not towards an unrelated MADB106 breast cancer cell line (Figure 11C). This evidence concerns the gene KCNMA1 and glioma.